Annals of Pediatric Cardiology
About us | Current Issue | Archives | Ahead of Print | Instructions | Submission | Subscribe | Advertise | Contact | Login 
 
CASE REPORT
Ahead of Print

Use of selexipag in a teenage patient with pulmonary arterial hypertension


1 Department of Pediatrics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ; PEDICOR-Pediatric and Perinatal Cardiology Center, Sao Jose dos Campos, SP, Brazil
2 Pulmonary Hypertension Center, Faculty of Medical Sciences, Santa Casa de Sao Paulo, Sao Paulo, SP, Brazil
3 PEDICOR-Pediatric and Perinatal Cardiology Center, Sao Jose dos Campos, SP, Brazil

Correspondence Address:
Nathalie Jeanne Magioli Bravo-Valenzuela,
Av. Andromeda, 693, s. 601-603, Zip Code: 12230-000, São José dos Campos- SP
Brazil
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/apc.APC_63_19

Pulmonary arterial hypertension (PAH) is a chronic, progressive, multifactorial disease. Currently, combination therapy is an attractive option for PAH management because three pathways (endothelin, nitric oxide, and prostacyclin) are involved in this disease. Selexipag is a novel oral prostacyclin pathway drug and is a highly selective IP prostacyclin receptor agonist with vasodilatory and antiproliferative effects. We report the case of a teenage patient with idiopathic PAH who presented in World Health Organization functional Class IV and showed no clinical improvement with dual therapy. We added oral selexipag to the treatment regimen and observed substantial improvement in her quality of life at the short-time follow-up. Despite the lack of childhood data regarding the use of selexipag in pediatric patients with PAH, the use of this drug in the current teenage patient improved her quality of life and exercise capacity.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Bravo-Valenzuela NJ
    -  Navarro F
    -  Silva SP
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed57    
    PDF Downloaded3    

Recommend this journal